PR Newswire Science
prCenter
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetingstranslating…
Patient-level matched analysis of real-world data demonstrated a significant 37% relative reduction in severe bleeding Significant reductions in 24-hour chest tube drainage and red blood cell transfusions were also seen, with no serious device-related adverse events reported…
Keywords#Significant#Real-World Data#Severe Bleeding#Reduction#Announces
Comments
Sign in to join the discussion.
Loading comments…